feed,title,long_url,short_url
Benzinga,"ANI Pharmaceuticals Shifts Focus From Generics To High-Margin Brand Assets, Analyst Sees Strong Potential",https://benzinga.com/analyst-ratings/analyst-color/24/10/41296581/ani-pharmaceuticals-shifts-focus-from-generics-to-high-margin-brand-assets-analyst-,https://da.gd/PVkzt
